We utilized a bioinformatic-driven approach to characterize the impact of TGFB2 mRNA, in combination with potential prognostic markers, on overall survival in breast cancer patients from The Cancer Genome Atlas (TCGA) database. The gene discussed is TGFB2; the disease is breast carcinoma.